Cargando…

A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome

BACKGROUND: To evaluate the safety of combination vaccine treatment of multiple peptides, phase I clinical trial was conducted for patients with advanced colorectal cancer using five novel HLA-A*2402-restricted peptides, three peptides derived from oncoantigens, ring finger protein 43 (RNF43), 34 kD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazama, Shoichi, Nakamura, Yusuke, Takenouchi, Hiroko, Suzuki, Nobuaki, Tsunedomi, Ryouichi, Inoue, Yuka, Tokuhisa, Yoshihiro, Iizuka, Norio, Yoshino, Shigefumi, Takeda, Kazuyoshi, Shinozaki, Hirokazu, Kamiya, Akira, Furukawa, Hiroyuki, Oka, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007571/ https://www.ncbi.nlm.nih.gov/pubmed/24612787 http://dx.doi.org/10.1186/1479-5876-12-63

Ejemplares similares

Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer
por: Kitahara, Masahiro, et al.
Publicado: (2016)

miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2017)

Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer
por: Inoue, Yuka, et al.
Publicado: (2017)

MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer
por: Kijima, Taiki, et al.
Publicado: (2017)

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
por: Hazama, Shoichi, et al.
Publicado: (2014)

Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarray
por: Tsunedomi, Ryouichi, et al.
Publicado: (2017)

Susceptibility of hepatoma-derived cells to histone deacetylase inhibitors is associated with ID2 expression
por: TSUNEDOMI, RYOUICHI, et al.
Publicado: (2013)

Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs
por: Hashimoto, Noriaki, et al.
Publicado: (2014)

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer
por: Suzuki, Nobuaki, et al.
Publicado: (2014)

Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)

A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes
por: TSUNEDOMI, RYOUICHI, et al.
Publicado: (2014)

A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model
por: HIGASHI, KOSUKE, et al.
Publicado: (2014)

miR‐125b‐1 and miR‐378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer
por: Tanaka, Hironori, et al.
Publicado: (2017)

Perioperative Microbiologic Monitoring of Sputum on Postoperative Day One as a Predictor of Pneumonia After Hepatectomy
por: Sakamoto, Kazuhiko, et al.
Publicado: (2015)

Metastatic ability and the epithelial‐mesenchymal transition in induced cancer stem‐like hepatoma cells
por: Nishiyama, Mitsuo, et al.
Publicado: (2018)

Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy
por: Matsui, Hiroto, et al.
Publicado: (2017)

Calreticulin is highly expressed in pancreatic cancer stem‐like cells
por: Matsukuma, Satoshi, et al.
Publicado: (2016)

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
por: Usui, Tatsuya, et al.
Publicado: (2018)

ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma
por: TSUNEDOMI, RYOUICHI, et al.
Publicado: (2013)

Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment
por: Usui, Tatsuya, et al.
Publicado: (2016)

High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer
por: Nakajima, Masao, et al.
Publicado: (2018)

Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
por: Kuwahara, Taichi, et al.
Publicado: (2019)

Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
por: Kuwahara, Taichi, et al.
Publicado: (2019)

Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity
por: Kanesada, Kou, et al.
Publicado: (2022)

An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
por: TOKUMITSU, YUKIO, et al.
Publicado: (2014)

Identification of a Promiscuous Epitope Peptide Derived From HSP70
por: Matsui, Hiroto, et al.
Publicado: (2019)

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2014)

Relationship Between Cytokine Gene Polymorphisms and Risk of Postoperative Pneumonia with Esophageal Cancer
por: Sakamoto, Kazuhiko, et al.
Publicado: (2014)

Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations
por: Maeda, Hiromichi, et al.
Publicado: (2014)

Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
por: Kamei, Ryoji, et al.
Publicado: (2018)

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials
por: Maeda, Hiromichi, et al.
Publicado: (2019)

Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance
por: Fujiwara, Yasuhiro, et al.
Publicado: (2021)

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS‐PC study
por: Suzuki, Nobuaki, et al.
Publicado: (2016)

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2017)

Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study
por: Matsukuma, Satoshi, et al.
Publicado: (2015)

Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes
por: Fujimoto, Takuya, et al.
Publicado: (2021)

Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells
por: Tsunedomi, Ryouichi, et al.
Publicado: (2022)

Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory
por: Herzenberg, LA, et al.
Publicado: (1982)

A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population
por: WATANABE, YUSAKU, et al.
Publicado: (2014)

Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract
por: Nagashima, Yukiko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4v62r1egvups7vm6j0t8m83kqt